Formic Acid

Formic Acid

SCHEMBL4663967

CN(C)CCCn1cnc2cc(-c3cc(Nc4ccc(NS(=O)(=O)c5c(F)cccc5F)cc4)ncn3)ccc21.O=CO

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 6/20 0.40
MAPK1 P28482 2/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
JAK1 P23458 2/20 0.37
JAK3 P52333 2/20 0.37
JAK2 O60674 1/20 0.37
CYP1A2 P05177 3/20 0.36
CYP2C9 P11712 3/20 0.36
CLK4 Q9HAZ1 3/20 0.36
USP2 O75604 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C19 P33261 2/20 0.36
TSHR P16473 1/20 0.36
TGFBR1 P36897 1/20 0.36
HTR6 P50406 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL4666063 0.92 NR1I2 (0.46) NR1I2MAPK1KDM4EPOLBMAPT
Formic Acid SCHEMBL4664322 0.88 NR1I2 (0.37) NR1I2MAPK1KDM4EPOLBMAPT
Formic Acid SCHEMBL4665678 0.85 HTT (0.41) NR1I2MAPTHTR6ALDH1A1ABL1
SCHEMBL4663971 0.85 MAPK1 (0.37) NR1I2MAPK1KDM4EPOLBMAPT
SCHEMBL4663918 0.84 BPTF (0.51) MAPK1KDM4EPOLBMAPTCYP1A2
Formic Acid SCHEMBL4666120 0.83 HTR6 (0.42) CYP1A2CYP2C9CLK4USP2CYP3A4
Formic Acid SCHEMBL4663826 0.82 JAK1 (0.42) MAPK1KDM4EPOLBMAPTJAK1
Formic Acid SCHEMBL4665783 0.81 HTR6 (0.41) CYP1A2CYP2C9CLK4USP2CYP3A4
SCHEMBL4666064 0.81 CYP1A2 (0.37) NR1I2MAPK1KDM4EPOLBMAPT
Formic Acid SCHEMBL4665819 0.80 HTR6 (0.46) CYP1A2CYP2C9CLK4USP2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242681-A1 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors ALTANA PHARMA AG (DE) 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242681-A1 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors MAP3K19, MAP3K6, MAP3K20 NR1I2 1040/4885MAPK1 32/4885KDM4E 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.